![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 24, 2015 10:57:12 AM
Short interest in NNVC? Now that's funny.
NanoViricides (NYSE:NNVC) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 2,539,026 shares, a drop of 1.5% from the March 13th total of 2,577,404 shares, AnalystRatings.Net reports. Currently, 6.1% of the shares of the company are sold short. Based on an average daily volume of 190,921 shares, the days-to-cover ratio is presently 13.3 days.
This level of short interest hasn't moved but a percent or so since December.
Anyone wasting their time shorting this stock with a daily dollar trading volume of less than 400K I would not consider a 'trader'.
I guess some people are ok with rolling the dice to make make 100 - 300 dollars over 13 days. Seems that no one on here seems to understand what the breakdown metrics of how many shorters vs daily trading volume multiplied by the stock price shows.
It shows chump change small time players, that's what it shows.
There are hundreds of stocks trading 10's to 100's of millions daily. That's where the real 'traders are. This stock wouldn't be worth anyone's time that had any real money. This is a plunk down 10k to 20k stock (chump change) and wait to see if the tech pans out. If not bye bye chump change. If so, hello a free million bucks.
Why anyone would continue day in and day out arguing over the missed timelines is (fill in the blank).
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM